These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2574414)

  • 1. Abuse liability of anxiolytics and sedative/hypnotics: methods assessing the likelihood of abuse.
    Roache JD; Griffiths RR
    NIDA Res Monogr; 1989; 92():123-46. PubMed ID: 2574414
    [No Abstract]   [Full Text] [Related]  

  • 2. Self-injection of barbiturates, benzodiazepines and other sedative-anxiolytics in baboons.
    Giffiths RR; Sannerud CA; Lamb RJ; Ator NA; Brady JV
    NIDA Res Monogr; 1990; 105():329. PubMed ID: 1678867
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessment of the abuse liability of buspirone in recreational sedative users.
    Cole JO; Orzack MH; Beake B; Bird M; Bar-Tal Y
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):69-75. PubMed ID: 6130076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determination of optimal posology for hypnotic and anxiolytic agents].
    Dreyfus JF; Puech J; Simon P; Boulenger JP; Couzinier JP; Garreau M; Guelfi JD; Guichoux JY; Hecquet S; Lefur G
    J Pharmacol; 1986; 17 Suppl 1():19-24. PubMed ID: 2875221
    [No Abstract]   [Full Text] [Related]  

  • 5. Relative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds.
    Griffiths RR; Johnson MW
    J Clin Psychiatry; 2005; 66 Suppl 9():31-41. PubMed ID: 16336040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypnotics-sedatives and anxiolytics].
    Agustí Maragall C
    Rev Enferm; 1981 Jul; 4(37):55-60. PubMed ID: 6118933
    [No Abstract]   [Full Text] [Related]  

  • 7. Anxiolytics and sedative/hypnotics dependence.
    Busto UE; Sellers EM
    Br J Addict; 1991 Dec; 86(12):1647-52. PubMed ID: 1686199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug self-administration procedures: alcohol and marijuana.
    Mello NK
    NIDA Res Monogr; 1989; 92():147-70. PubMed ID: 2512491
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of choice procedures for assessing the reinforcing properties of drugs in humans.
    Johanson CE; de Wit H
    NIDA Res Monogr; 1989; 92():171-210. PubMed ID: 2512492
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationship between self-reported drug effects and their reinforcing effects: studies with stimulant drugs.
    Fischman MW
    NIDA Res Monogr; 1989; 92():211-30. PubMed ID: 2512494
    [No Abstract]   [Full Text] [Related]  

  • 11. Anxiolytics and sedatives and risk of fractures: effects of half-life.
    Vestergaard P; Rejnmark L; Mosekilde L
    Calcif Tissue Int; 2008 Jan; 82(1):34-43. PubMed ID: 18175030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abuse liability assessment of anxiolytics/hypnotics: rationale and laboratory lore.
    Evans SM; Critchfield TS; Griffiths RR
    Br J Addict; 1991 Dec; 86(12):1625-32. PubMed ID: 1686197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New anxiolytic drugs: methodological issues].
    Ginestet D; Corruble E
    Encephale; 1993; 19(6):627-37. PubMed ID: 12404782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulant depressant report.
    Johanson CE
    NIDA Res Monogr; 1986; 67():98-104. PubMed ID: 2875394
    [No Abstract]   [Full Text] [Related]  

  • 15. Self-injection of barbiturates, benzodiazepines and other sedative-anxiolytics in baboons.
    Griffiths RR; Lamb RJ; Sannerud CA; Ator NA; Brady JV
    Psychopharmacology (Berl); 1991; 103(2):154-61. PubMed ID: 1674158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selectivity in the generalization profile in baboons trained to discriminate lorazepam: benzodiazepines, barbiturates and other sedative/anxiolytics.
    Ator NA; Griffiths RR
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1442-57. PubMed ID: 9316858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of combined sedative and anxiolytic preparations on subjective aspects of sleep and objective measure of arousal and performance the morning following nocturnal medication. II. Repeated doses.
    Hindmarch I; Parrott AC
    Arzneimittelforschung; 1980; 30(7):1167-70. PubMed ID: 6106501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance to a new class of non-benzodiazepine anxiolytics.
    Chodera A; Nowakowska E; Bartczak G
    Pol J Pharmacol; 1994; 46(5):479-81. PubMed ID: 7894538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New anxiolytic rating scale [proceedings].
    Wang RI; Larson C
    Psychopharmacol Bull; 1977 Apr; 13(2):6-8. PubMed ID: 16311
    [No Abstract]   [Full Text] [Related]  

  • 20. Relation between discriminative and reinforcing effects of midazolam, pentobarbital, chlordiazepoxide, zolpidem, and imidazenil in baboons.
    Ator NA
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):477-87. PubMed ID: 12373448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.